Latest Asx News

Noble Helium has upgraded its North Rukwa helium resource estimate by nearly 30%, driven by fresh data and a refined charge model, setting the stage for a targeted drilling campaign.

Global Lithium Resources has made significant progress on its Manna Lithium Project, advancing its Definitive Feasibility Study and securing a key variation to its offtake agreement with Canmax. The company also reported a substantial reduction in its cash burn rate, maintaining a strong cash position.

Proteomics International Laboratories has secured $12 million to fast-track its precision diagnostic tests, including the US launch of PromarkerD for diabetic kidney disease, backed by a new AMA billing code. The company also advances its pipeline with new patents and commercial partnerships.

QMines Limited reports promising high-grade copper and zinc intersections from its maiden drilling at Sulphide City, bolstering confidence in the Develin Creek project’s potential.

Torque Metals has initiated diamond drilling at its Paris Gold Project to extend promising high-grade gold mineralisation, leveraging government co-funding and advanced geophysical targeting.

Global Health Limited reported a robust June quarter with a 65% rise in annual sales and a strategic pivot towards AI-driven efficiencies, aiming for profitability by mid-2026.

NEXION Group has completed the sale of its data centre subsidiary to Carrier Connect for AUD 2.5 million, marking a strategic shift to sharpen its focus on core network and AI software businesses.

Elanor Investors Group announces a $125 million strategic investment from Rockworth Capital Partners to stabilise its balance sheet and fund growth, including the acquisition of Singapore’s Firmus Capital.

Strickland Metals has reported outstanding metallurgical testwork results from its Gradina Deposit in Serbia, achieving gold recoveries up to 97.9% and averaging nearly 90%. This milestone supports the upcoming maiden Mineral Resource Estimate and ongoing project development.

Elanor Investors Group announces a $125 million recapitalisation through an expanded alliance with Rockworth Capital Partners, including the acquisition of Singapore’s Firmus Capital and a strategic shift towards Pan-Asian real estate markets.

Radiopharm Theranostics has received FDA clearance to begin a Phase I clinical trial for RV-01, a novel radiopharmaceutical targeting the 4Ig isoform of B7-H3 in solid tumors, marking a significant step forward in cancer treatment innovation.

Mt Malcolm Mines has initiated a significant 2,000-metre drilling campaign at its Sunday Picnic Prospect, aiming to refine gold resource estimates and advance mining lease consolidation in Western Australia’s Eastern Goldfields.